• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, May 14, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Caution urged for Australian optometrists considering cosmetic scope expansion

by Myles Hume
March 13, 2024
in Ahpra/National Boards, Local, News, Ophthalmic insights, Policy & regulation
Reading Time: 5 mins read
A A
IPL has prompted optometrists to consider non-surgical cosmetic procedures. 
Image: Juta/Shutterstock.com.

IPL has prompted optometrists to consider non-surgical cosmetic procedures. Image: Juta/Shutterstock.com.

Share on FacebookShare on Twitter

The recent arrival of non-surgical equipment targeted at primary eyecare professionals and a willingness to diversify optometry businesses through more privately billed services are driving greater interest in cosmetic procedures among Australian optometrists, Optometry Australia says. 

However, practitioners seeking to broaden their scope by offering non-surgical, eye-related cosmetic services are being urged to consider any implications around their professional indemnity insurance (PII) cover, and remain on top of proposed regulations set to determine how such services can be marketed to the public. 

Luke Arundel. Image: Optometry Australia.

The notion of optometrists performing cosmetic services is nothing new, but the advent of intense pulsed light (IPL) therapy and – during the past 12 months – new bipolar radiofrequency and micro needling to rejuvenate the periorbital region from aesthetics company InMode have prompted renewed interest in the area. 

The trend has already taken off in the US where the industry has coined the term “ocular aesthetics”. Historically, these services were limited to surgeries such as blepharoplasty and other eyelid procedures such as ptosis, entropion and ectropion, but new non-surgical methods have allowed optometry to enter the picture. 

OA chief clinical officer Mr Luke Arundel concurred, telling Insight the recent release of new non-invasive and non-surgical equipment for cosmetic procedures was likely the primary driver for some OA member optometrists to consider broadening the range of services they offer to patients.  

“Many practices are also looking to decrease reliance on dispensing income through offering a range of privately billed services, which is an area Optometry Australia has been active in supporting members to introduce, with many resources available in this area on our website,” he said.

 Arundel said Australian optometrists had been performing cosmetic procedures for many decades, including cosmetic shells or lenses for damaged or disfigured eyes, and coloured contact lenses.

“Or, as far as Medicare is concerned, fitting prescription contact lenses to any patient under +/- 5.00D,” he said.

“Optometrists have for many years also been assisting dry eye patients through application of IPL. Treatment of vascular lesions like rosacea may be an obvious complimentary adjunct with dry eye therapy. While in the early days, we will be monitoring with interest use of new devices in Australia which may be able to assist with non-surgical blepharoplasty through RF microneedling.”

 Arundel said OA had fielded inquiries through its Optometry Advisor Help Desk, with optometrists curious about regulation, scope-of-practice, advertising rules and restrictions and coverage for techniques through PII.

Regarding the implications for PII, he added: “It would be sensible for optometrists to seek advice from their professional indemnity insurance provider, or financial advisor to ensure their PII covers all the techniques they wish to use if considering expanding into cosmetic work.”

Regulator review 

Meanwhile, the Australian Health Practitioner Regulation Agency (Ahpra) is putting non-surgical cosmetic procedures under the microscope that will likely lead to clearer rules around who can perform them and guidelines on advertising.

Amid the crackdown, there is expected to be tighter regulations around the use of testimonials and how before and after images are used to demonstrate results. 

Ahpra is concerned about the non-surgical cosmetic sector due to what it described as a lack of clear information about the qualifications and experience of practitioners, and advertising that minimises the risk and complexity of procedures or implies unrealistic results. 

It’s also worried about the number of young and potentially vulnerable people seeking out non-surgical cosmetic services, financial gains that can sometimes outweigh patient wellbeing and safety, and ongoing cost and frequency of procedures to maintain outcomes.

Arundel said with this review under way, optometrists looking to move into non-surgical cosmetic services should be aware that current guidelines may change in the near future.

“As part of the association’s strategic plan to lead the sector, Optometry Australia does input into all consultations affecting optometrists and this consultation has been recently been extended to accommodate for the holiday season, with submissions closing on 1 March 2024,” he said. 

“In addition, new National Safety and Quality Cosmetic Surgery Standards were launched late last year, following broad consultation with consumers, clinicians, services, professional and peak bodies, regulators, and other representatives of the sector. These standards aim to protect the public from harm and improve the quality of cosmetic surgery in Australia.”

Timeline and key points:

• In September 2022, an independent review is released regarding regulation of medical practitioners performing cosmetic surgery and made 16 recommendations – that were all accepted Ahpra and the Medical Board.

• In July 2023, the Medical Board’s new guidelines for doctors performing cosmetic surgery came into effect. 

• Ahpra noted: “The comments by the independent review that the cosmetic surgery sector ‘is unique and somewhat of a health market disrupter, largely sitting outside of the existing health system frameworks’ are equally relevant to non-surgical cosmetic procedures.”

• For example, Medicare item numbers are not available for non-surgical cosmetic procedures, these procedures are not offered by the public health system and they are generally not covered by private health insurance.

• The draft guidelines emphasise practitioners’ responsibilities around informed consent, including financial consent, and consideration of patient suitability, including assessment for underlying psychological conditions such as body dysmorphic disorder (BDD). 

• Ahpra said inappropriate advertising of non-surgical cosmetic procedures has the potential to pathologise normal changes in appearance, exploit vulnerabilities or insecurities of individuals, contribute to poor body image and create unrealistic expectations.

• Consultation ended 1 March 2024.  

More reading

Queensland clinic first to introduce InMode’s dry eye treatment

New regulations expected for optometrists performing non-surgical cosmetic procedures

Ophthalmic sector watchful of Ahpra clampdown on ‘cosmetic surgeon’ title

Related Posts

Anxious patients can be more restless during surgery, risking complications. Image: Vision Eye Institute.

Taming the tremors in refractive surgery

by Staff Writer
May 13, 2025

Refractive surgery, while a life-changing procedure for many, can be a significant source of anxiety for patients. Anecdotally, we observed...

There were 1,156 allegations to Ahpra of ‘boundary violations’ in 2023-24. 
Image: Pormezz/Shutterstock.com.

Ahpra reforms: Sexual misconduct on register permanently

by Staff Writer
May 13, 2025

Optometrists, ophthalmologists and other registered Australian practitioners proven to have committed sexual misconduct will have this information permanently published against...

Each year, Vision Australia helps between 80 and 100 people with blindness and low vision into employment.  Image: Vision Australia.

Vision Australia – working to give people a future and a ‘fair go’

by Rob Mitchell
May 12, 2025

A diagnosis of permanent vision loss is not the end. At Vision Australia it’s the start of a new journey...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited